Study Results
Results pending
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
Recruitment Status
UNKNOWN
Clinical Phase
NA
Total Enrollment
30 participants
Study Classification
INTERVENTIONAL
Study Start Date
2014-03-31
Study Completion Date
2017-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study will evaluate the efficacy of an advice with a weekly divided drug delivery, compared to an usual monthly delivery in the prevention of voluntary drug intoxications repeated.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Voluntary Drug Poisoning by Psychoactive Molecules: Identify Cognitive Markers
NCT03481192
Suicide
Drug Poisoning
UNKNOWN
NA
Epidemiology of Acute Self-poisoning in Emergency Services in France
NCT02518386
Suicide Attempts
COMPLETED
New Psychoactive Substances in Intoxicated Patients During the Winter Activities
NCT04155281
Acute Intoxication
Psychoactive Substance Use
COMPLETED
Differential Acute Tolerance Development to Effects of Nitrous Oxide - 7
NCT00000255
Opioid-Related Disorders
Substance-Related Disorders
COMPLETED
PHASE2
Systemic Ketamine for the Improvement of Post-Operative Analgesia at the Alcohol-Dependent Patient
NCT00329394
Alcoholic Patient
Carcinological Surgery ORL
SUSPENDED
PHASE3
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Hospitalized for Voluntary Drug Intoxication
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
Allocation Method
RANDOMIZED
Intervention Model
PARALLEL
Blinding Strategy
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Weekly divided delivery
Hospitalized for voluntary drug intoxications.
Group Type
ACTIVE_COMPARATOR
Weekly divided delivery
Intervention Type
OTHER
Monthly divided delivery
Hospitalized for voluntary drug intoxications.
Group Type
ACTIVE_COMPARATOR
Monthly divided delivery
Intervention Type
OTHER
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Weekly divided delivery
Intervention Type
OTHER
Monthly divided delivery
Intervention Type
OTHER
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Men and women between 18 and 65 years.
* Hospitalized after a voluntary drug intoxication.
* History of two voluntary drug intoxications at least.
* Person registered for social security.
* Signed free consent.
* Hospitalized after a voluntary drug intoxication.
* History of two voluntary drug intoxications at least.
* Person registered for social security.
* Signed free consent.
Exclusion Criteria
* Patients under treatment for opiate split
* Acute or chronicgoing wild.
* Cognitive problems hindering understanding of questionnaires
* Persons targeted by articles L1121-5 to L1121-8 of CSP
* Acute or chronicgoing wild.
* Cognitive problems hindering understanding of questionnaires
* Persons targeted by articles L1121-5 to L1121-8 of CSP
Minimum Eligible Age
18 Years
Maximum Eligible Age
65 Years
Eligible Sex
ALL
Accepts Healthy Volunteers
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Grenoble
OTHER
Sponsor Role
lead
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Responsibility Role
SPONSOR
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maurice Dematteis, Professor
Role: PRINCIPAL_INVESTIGATOR
Grenoble Hospital University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UniversityHospitalGrenoble
La Tronche, , France
Site Status
RECRUITING
Countries
Review the countries where the study has at least one active or historical site.
France
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, de Girolamo G, Graaf R, Demyttenaere K, Gasquet I, Haro JM, Katz SJ, Kessler RC, Kovess V, Lepine JP, Ormel J, Polidori G, Russo LJ, Vilagut G, Almansa J, Arbabzadeh-Bouchez S, Autonell J, Bernal M, Buist-Bouwman MA, Codony M, Domingo-Salvany A, Ferrer M, Joo SS, Martinez-Alonso M, Matschinger H, Mazzi F, Morgan Z, Morosini P, Palacin C, Romera B, Taub N, Vollebergh WA; ESEMeD/MHEDEA 2000 Investigators, European Study of the Epidemiology of Mental Disorders (ESEMeD) Project. Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl. 2004;(420):55-64. doi: 10.1111/j.1600-0047.2004.00331.x.
Reference Type
BACKGROUND
Aouba, A., Péquignot, F., Camelin, L., Laurent, F., Jougla, E. La mortalité par suicide en France en 2006. Etudes et résultats. 2009 ; (702) : 1-8.
Reference Type
BACKGROUND
Beck, F., Guignard, R., Du Roscoät, E., Saïas, T. Tentatives de suicide et pensées suicidaires en France en 2010. Bulletin épidémiologique hebdomadaire. 2011 ; 47-48 : 488-492.
Reference Type
BACKGROUND
Camidge DR, Wood RJ, Bateman DN. The epidemiology of self-poisoning in the UK. Br J Clin Pharmacol. 2003 Dec;56(6):613-9. doi: 10.1046/j.1365-2125.2003.01910.x.
Reference Type
BACKGROUND
Carter GL, Clover K, Whyte IM, Dawson AH, D'Este C. Postcards from the EDge: 24-month outcomes of a randomised controlled trial for hospital-treated self-poisoning. Br J Psychiatry. 2007 Dec;191:548-53. doi: 10.1192/bjp.bp.107.038406.
Reference Type
BACKGROUND
Chan-Chee, C., & Jezewski-Serra, D. Hospitalisations pour tentatives de suicide entre 2004 et 2007 en France métropolitaine. Analyse du PMSI-MCO. Bulletin épidémiologique hebdomadaire. 2011 ; 47-48 : 492-496.
Reference Type
BACKGROUND
Coben JH, Davis SM, Furbee PM, Sikora RD, Tillotson RD, Bossarte RM. Hospitalizations for poisoning by prescription opioids, sedatives, and tranquilizers. Am J Prev Med. 2010 May;38(5):517-24. doi: 10.1016/j.amepre.2010.01.022.
Reference Type
BACKGROUND
Dumesnil, S., Grandfils, N., Le Fur, P., Mizrahi, A. Mizrahi, A. Santé, Soins et protection Sociale en France en 1996. CREDES (en ligne). Novembre 1997, (consulté le 3/4/12).
Reference Type
BACKGROUND
Fedyszyn IE, Harris MG, Robinson J, Edwards J, Paxton SJ. Characteristics of suicide attempts in young people undergoing treatment for first episode psychosis. Aust N Z J Psychiatry. 2011 Oct;45(10):838-45. doi: 10.3109/00048674.2011.595687. Epub 2011 Aug 23.
Reference Type
BACKGROUND
Florentine JB, Crane C. Suicide prevention by limiting access to methods: a review of theory and practice. Soc Sci Med. 2010 May;70(10):1626-32. doi: 10.1016/j.socscimed.2010.01.029. Epub 2010 Feb 12.
Reference Type
BACKGROUND
Fournet, N., Caillère, N., Fouillet, A., Caserio-Schönemann, C., Josseran, L. Le système français de surveillance sanitaire des urgences et des décès (Sur-SaUD®). Saint-Maurice : Institut de veille sanitaire : 2011. 12p.
Reference Type
BACKGROUND
Gasquet I, Negre-Pages L, Fourrier A, Nachbaur G, El-Hasnaoui A, Kovess V, Lepine JP. [Psychotropic drug use and mental psychiatric disorders in France; results of the general population ESEMeD/MHEDEA 2000 epidemiological study]. Encephale. 2005 Mar-Apr;31(2):195-206. doi: 10.1016/s0013-7006(05)82386-3. French.
Reference Type
BACKGROUND
Hawton K, van Heeringen K. Suicide. Lancet. 2009 Apr 18;373(9672):1372-81. doi: 10.1016/S0140-6736(09)60372-X.
Reference Type
BACKGROUND
Hovda KE, Bjornaas MA, Skog K, Opdahl A, Drottning P, Ekeberg O, Jacobsen D. Acute poisonings treated in hospitals in Oslo: a one-year prospective study (I): pattern of poisoning. Clin Toxicol (Phila). 2008 Jan;46(1):35-41. doi: 10.1080/15563650601185969.
Reference Type
BACKGROUND
Kapur N, Cooper J, Hiroeh U, May C, Appleby L, House A. Emergency department management and outcome for self-poisoning: a cohort study. Gen Hosp Psychiatry. 2004 Jan-Feb;26(1):36-41. doi: 10.1016/j.genhosppsych.2003.06.002.
Reference Type
BACKGROUND
Lamprecht HC, Pakrasi S, Gash A, Swann AG. Deliberate self-harm in older people revisited. Int J Geriatr Psychiatry. 2005 Nov;20(11):1090-6. doi: 10.1002/gps.1404.
Reference Type
BACKGROUND
Large MM, Nielssen OB. Suicide in Australia: meta-analysis of rates and methods of suicide between 1988 and 2007. Med J Aust. 2010 Apr 19;192(8):432-7. doi: 10.5694/j.1326-5377.2010.tb03580.x.
Reference Type
BACKGROUND
Le Pont F, Letrilliart L, Massari V, Dorleans Y, Thomas G, Flahault A. Suicide and attempted suicide in France: results of a general practice sentinel network, 1999-2001. Br J Gen Pract. 2004 Apr;54(501):282-4.
Reference Type
BACKGROUND
Manchikanti L, Whitfield E, Pallone F. Evolution of the National All Schedules Prescription Electronic Reporting Act (NASPER): a public law for balancing treatment of pain and drug abuse and diversion. Pain Physician. 2005 Oct;8(4):335-47.
Reference Type
BACKGROUND
Mann JJ, Apter A, Bertolote J, Beautrais A, Currier D, Haas A, Hegerl U, Lonnqvist J, Malone K, Marusic A, Mehlum L, Patton G, Phillips M, Rutz W, Rihmer Z, Schmidtke A, Shaffer D, Silverman M, Takahashi Y, Varnik A, Wasserman D, Yip P, Hendin H. Suicide prevention strategies: a systematic review. JAMA. 2005 Oct 26;294(16):2064-74. doi: 10.1001/jama.294.16.2064.
Reference Type
BACKGROUND
Mateos Rodríguez, A.A, Huerta Arroyo, A., Benito Vellisca, M.A. The epidemiology of suicide attempts using drugs. Emergencias. 2007 ; 19 : 251-254.
Reference Type
BACKGROUND
Mauri MC, Cerveri G, Volonteri LS, Fiorentini A, Colasanti A, Manfre S, Borghini R, Pannacciulli E. Parasuicide and drug self-poisoning: analysis of the epidemiological and clinical variables of the patients admitted to the Poisoning Treatment Centre (CAV), Niguarda General Hospital, Milan. Clin Pract Epidemiol Ment Health. 2005 Apr 28;1(1):5. doi: 10.1186/1745-0179-1-5.
Reference Type
BACKGROUND
Michel, G., Aquaviva, E., Aubron, V., Purper-ouakil, D. Suicides : mieux comprendre, pour prévenir avec plus d'efficacité. In : Beck F, Guilbert P, Gautier A (dir). Baromètre santé 2005. Saint-Denis : Inpes. 2007 ; 487-506.
Reference Type
BACKGROUND
Mouquet, M.C., & Bellamy, V. Suicides et tentatives de suicide en France. Etudes et Résutlats. 2006 ; 488 :1-8.
Reference Type
BACKGROUND
Nordentoft M. Prevention of suicide and attempted suicide in Denmark. Epidemiological studies of suicide and intervention studies in selected risk groups. Dan Med Bull. 2007 Nov;54(4):306-69.
Reference Type
BACKGROUND
Owens D, Horrocks J, House A. Fatal and non-fatal repetition of self-harm. Systematic review. Br J Psychiatry. 2002 Sep;181:193-9. doi: 10.1192/bjp.181.3.193.
Reference Type
BACKGROUND
Prescott K, Stratton R, Freyer A, Hall I, Le Jeune I. Detailed analyses of self-poisoning episodes presenting to a large regional teaching hospital in the UK. Br J Clin Pharmacol. 2009 Aug;68(2):260-8. doi: 10.1111/j.1365-2125.2009.03458.x.
Reference Type
BACKGROUND
Rodríguez, A.A.M., Arroyo, A.H., and Vellisca, M.A.B. (2007). The epidemiology of suicide attempts using drugs. Emergencias. 2007 ; 19 : 251-254.
Reference Type
BACKGROUND
Saviuc, P., Bedry, R., Flesch, F. Epidémiologie des intoxications médicamenteuses volontaires. Médecine Thérapeutique. 1999; 5(1): 45-8.
Reference Type
BACKGROUND
Staikowsky F, Theil F, Candella S. [Trends in the pharmaceutical profile of intentional drug overdoses seen in the emergency room]. Presse Med. 2005 Jul 2;34(12):842-6. doi: 10.1016/s0755-4982(05)84060-6. French.
Reference Type
BACKGROUND
Simoni-Wastila L, Tompkins C. Balancing diversion control and medical necessity: the case of prescription drugs with abuse potential. Subst Use Misuse. 2001 Jul-Aug;36(9-10):1275-96. doi: 10.1081/ja-100106227.
Reference Type
BACKGROUND
Theil, F. Evolution qualitative des médicaments incriminés dans les intoxications médicamenteuses sur une période de 10 ans. Créteil (Paris XII). 64 pages. 2007. (Thèse de médecine).
Reference Type
BACKGROUND
Tournier M, Grolleau A, Cougnard A, Molimard M, Verdoux H. Factors associated with choice of psychotropic drugs used for intentional drug overdose. Eur Arch Psychiatry Clin Neurosci. 2009 Mar;259(2):86-91. doi: 10.1007/s00406-008-0839-2. Epub 2008 Sep 19.
Reference Type
BACKGROUND
Vaiva G, Vaiva G, Ducrocq F, Meyer P, Mathieu D, Philippe A, Libersa C, Goudemand M. Effect of telephone contact on further suicide attempts in patients discharged from an emergency department: randomised controlled study. BMJ. 2006 May 27;332(7552):1241-5. doi: 10.1136/bmj.332.7552.1241.
Reference Type
BACKGROUND
Vlad IA, Fatovich DM, Fenner SG, Daly FF, Soderstrom JH, Burrows SA. Patient perceptions of the potential lethality associated with deliberate self-poisoning. Emerg Med Australas. 2011 Oct;23(5):580-6. doi: 10.1111/j.1742-6723.2011.01434.x. Epub 2011 Jun 15.
Reference Type
BACKGROUND
Related Links
Access external resources that provide additional context or updates about the study.
http://www.irdes.fr/Publications/Rapports1997/rap1204.pdf
Soins et protection Sociale en France en 1996. CREDES
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
38RC13.577
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.
Identification of Psychoactive Substance Users in Young Adults (16 to 25 Years Old) Visiting the Emergency Department
NCT04173546
COMPLETED
Acute Dose-dependent Effects of DMT in Healthy Subjects
NCT05384678
COMPLETED
PHASE1
Psychoactive Drug Uses Among Medical and Pharmacy Students
NCT05115981
COMPLETED
Lack of Acute Tolerance Development to Effects of Nitrous Oxide - 4
NCT00000252
COMPLETED
PHASE2
Identification of Iatrogenic Drug Events Upon Admission to the Adult Emergency Departments
NCT07333131
RECRUITING
Dopamine and Opioid Receptor Antagonists Reduce Cue-induced Reward Responding and Reward Impulsivity
NCT02557984
COMPLETED
NA
Medication Reconciliation in an Emergency Department: How to Prioritize Patients ?
NCT03955965
COMPLETED
Marijuana Drug Discrimination and Self-Administration
NCT00943930
COMPLETED
PK/PD of Oral and Vaporized Delta-9-Tetrahydrocannabinol (THC) in Older Adults
NCT05906511
RECRUITING
EARLY_PHASE1
Adverse Drug Events at Emergency Department
NCT03442010
COMPLETED
Evaluation of the Management of Tramadol Use Disorders
NCT04550754
COMPLETED
Cannabioids as a New Intervention for Amphetamine Dependence
NCT02952196
WITHDRAWN
PHASE2
Brief Motivational Intervention (BMI) on the Deprescription of Benzodiazepines and Related Substances in Adult Chronic Drug Users
NCT06446349
RECRUITING
NA
Acute Dose-dependent Effects of DMT-bolus Applications in Healthy Subjects (DMT BDR-Study)
NCT05695495
COMPLETED
PHASE1
Development of a Valid Test Battery for Assessing Driving Ability When Influenced by Drugs.
NCT00967421
COMPLETED
NA
Pharmacological Interaction Between Carvedilol and Methylenedioxymethamphetamine (MDMA)
NCT01270672
COMPLETED
NA
Single and Repeat Doses of DMT in Healthy Subjects
NCT05559931
ACTIVE_NOT_RECRUITING
PHASE1
Dose Escalation Study of Intravenous Baclofen in Healthy Adult Volunteers
NCT01931319
COMPLETED
PHASE1
A Study of The Abuse Liability Potential of RO4917838 in Recreational Drug Users
NCT01438749
COMPLETED
PHASE1
Ketamine for Low Mood States in the ER
NCT01209845
COMPLETED
PHASE1
A Study of the Abuse Potential of Dronabinol in Recreational Cannabinoid Users
NCT02094599
COMPLETED
PHASE1
Study of the Relationship Between Dose-concentration-effect of Delta-9-tetrahydrocannabinol (THC) and the Ability to Drive in Chronic or Occasional Cannabis Users
NCT02061020
COMPLETED
NA
Study to Evaluate the Abuse Potential of ACT-541468 in Healthy Recreational Drug Users
NCT03657355
COMPLETED
PHASE1
Taking Account of Inobservable Periods in Longitudinal Drug Treatment Follow-up
NCT02827331
COMPLETED
Drug Discrimination in Methadone-Maintained Humans Study 3
NCT01068847
COMPLETED
PHASE1